Drug–device combination products are becoming a defining feature of modern pharmaceutical portfolios, shaping how therapies differentiate, extend...
In this webinar recap, David Johnson, Sales & Marketing Director at 3P innovation, and Tracy Moore, Principal Consultant at TM Pharma and former...
As the pharmaceutical industry advances into more complex modalities, from biologics to cell and gene therapies, the need for flexible,...